Vita Life Sciences (ASX:VLS) Net Income From Continuing Operations : A$9.08 Mil (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Vita Life Sciences Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Vita Life Sciences's net income from continuing operations for the six months ended in Dec. 2023 was A$5.09 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was A$9.08 Mil.

Vita Life Sciences Net Income From Continuing Operations Historical Data

The historical data trend for Vita Life Sciences's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita Life Sciences Net Income From Continuing Operations Chart

Vita Life Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

3.09

5.86

8.25

7.34

9.08

Vita Life Sciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Income From Continuing Operations	Get a 7-Day Free Trial															4.57	3.64	3.70	3.98	5.09

Vita Life Sciences Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$9.08 Mil.

Vita Life Sciences (ASX:VLS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vita Life Sciences Ltd (ASX:VLS) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bath Road Kirrawee, Unit 1/ 102, Sydney, NSW, AUS, 2232

Website

https://www.vitalifesciences.com

Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands throughout Asia-Pacific region.

Vita Life Sciences (ASX:VLS) Headlines

No Headlines